Analytical R&D
Product Description
Conscio Group
-
Country/Region:Germany
-
On CPHI since:2015
-
Certificates:4
-
Employees:500 - 999
Company types
Primary activities
Categories
Conscio Group
-
Country/Region:Germany
-
On CPHI since:2015
-
Certificates:4
-
Employees:500 - 999
Company types
Primary activities
More Products from Conscio Group (6)
-
Product Formulation development
Conscio provides comprehensive formulation development services, from early feasibility and proof-of-concept studies to advanced formulation design, process optimisation, and upscaling for clinical supply. We support a broad range of projects, including new chemical entities (NCE), new therapeutic entities... -
Product Clinical trials
Conscio offers a comprehensive portfolio of early-phase clinical trial services, underpinned by decades of expertise and integrated departmental cooperation. Our two fully equipped clinical units in the Czech Republic have a combined capacity of 96 beds and deliver high-quality, regulatory-compliant studie... -
Product Bioanalytical testing
We provide analytical services from pre-clinical studies through Phase III, including full statistical evaluation. Our experienced team has successfully completed more than 780 biostudies for pharmaceutical companies across Europe, the United States, Asia, and Australia.
The Bioanalytical de... -
Product Quality control: Pharmaceuticals
The Pharmaceutical Analyses Department provides precise and reliable testing to support pharmaceutical development, manufacturing, and quality control. All activities are performed under Good Manufacturing Practice (GMP) and in accordance with current ICH guidelines. Using advanced analytical methods and m... -
Product Quality Control: Biologics and Biosimilars
The Biopharmaceutical Analyses Department provides comprehensive analytical services to support the development, characterisation, and quality control of biologics and biosimilars. Our expertise covers a wide spectrum of molecules, including peptides, monoclonal antibodies, fusion proteins, and antibody–dr... -
Product IMP Manufacturing
GMP-compliant manufacturing of investigational medicinal products (IMPs) is carried out in a fully equipped 1,340 m² facility designed for small-scale production to meet clinical trial needs, including Phase I, Phase II, pilot, and bioequivalence (BE) studies. Services cover the full process from developme...





